Using genome-wide complex trait analysis to quantify ‘missing heritability’ in Parkinson’s disease
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Genome-wide association studies (GWASs) have been successful at identifying single-nucleotide polymorphisms (SNPs) highly associated with common traits; however, a great deal of the heritable variation associated with common traits remains unaccounted for within the genome. Genome-wide complex trait analysis (GCTA) is a statistical method that applies a linear mixed model to estimate phenotypic variance of complex traits explained by genome-wide SNPs, including those not associated with the trait in a GWAS. We applied GCTA to 8 cohorts containing 7096 case and 19 455 control individuals of European ancestry in order to examine the missing heritability present in Parkinson's disease (PD). We meta-analyzed our initial results to produce robust heritability estimates for PD types across cohorts. Our results identify 27% (95% CI 17-38, P = 8.08E - 08) phenotypic variance associated with all types of PD, 15% (95% CI -0.2 to 33, P = 0.09) phenotypic variance associated with early-onset PD and 31% (95% CI 17-44, P = 1.34E - 05) phenotypic variance associated with late-onset PD. This is a substantial increase from the genetic variance identified by top GWAS hits alone (between 3 and 5%) and indicates there are substantially more risk loci to be identified. Our results suggest that although GWASs are a useful tool in identifying the most common variants associated with complex disease, a great deal of common variants of small effect remain to be discovered.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
Principal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248 · cited 1×
“All analyses were adjusted for eigenvectors 1–20 from principal component analyses to account for possible confounding by population substructure within each cohort (22,43).”
MethodFinding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
GCTA: a tool for genome-wide complex trait analysis
Yang, J., Lee, S. H., Goddard, M. E., & Visscher, P. M. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.11.011 · Cited by 8,279 · cited 15×
“It was necessary to employ more stringent quality control that what is generally acceptable for GWASs because systematic differences between cases and controls could be picked up as genetic variance (3).”
BackgroundMethodInfluentialThe combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380
Common SNPs explain a large proportion of the heritability for human height
Yang, J., Benyamin, B., McEvoy, B. P., Gordon, S., Henders, A. K., Nyholt, D. R., Madden, P. A., Heath, A. C., Martin, N. G., Montgomery, G. W., et al. (2010) · Nature Genetics · doi:10.1038/ng.608 · Cited by 4,446 · cited 2×
“case population and to control for ascertainment, we used GCTA to transform the explained variance estimate from the observed scale (V(1)/Vp) to the underlying scale (V(1)/ Vp_L).”
Methodα-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Self-citationMulticenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135
Self-citationMaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes
Li, Y., Willer, C. J., Ding, J., Scheet, P., & Abecasis, G. R. (2010) · Genetic Epidemiology · doi:10.1002/gepi.20533 · Cited by 1,843 · cited 5×
“A quality threshold of a minimum 0.30 squared correlation between proximal, experimental and imputed genotypes was applied, indicated by the R 2 metric from MACH (41,42).”
MethodInfluential
Research works printed but not linked: 1
- 2011, 8, e1002548
Cited by
Nalls, M. A., Blauwendraat, C., Vallerga, C. L., Heilbron, K., Bandres-Ciga, S., Chang, D., Tan, M., Kia, D. A., Noyce, A. J., Xue, A., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30320-5 · Cited by 2,454
Self-citationAnalysis of shared heritability in common disorders of the brain
The Brainstorm Consortium, Anttila, V., Bulik-Sullivan, B., Finucane, H. K., Walters, R. K., Bras, J., Duncan, L., Escott-Price, V., Falcone, G. J., Gormley, P., et al. (2018) · Science · doi:10.1126/science.aap8757 · Cited by 1,924
International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895
Self-citationA meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci
Chang, D., Nalls, M. A., Hallgrímsdóttir, I. B., Hunkapiller, J., van der Brug, M., Cai, F., International Parkinson's Disease Genomics Consortium, 23andMe Research Team, Kerchner, G. A., Ayalon, G., et al. (2017) · Nature Genetics · doi:10.1038/ng.3955 · Cited by 1,112
Self-citationReevaluation of SNP heritability in complex human traits
the UCLEB Consortium, Speed, D., Cai, N., Johnson, M. R., Nejentsev, S., & Balding, D. J. (2017) · Nature Genetics · doi:10.1038/ng.3865 · Cited by 456
Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease
Robak, L. A., Jansen, I. E., van Rooij, J., Uitterlinden, A. G., Kraaij, R., Jankovic, J., Heutink, P., Shulman, J. M., International Parkinson’s Disease Genomics Consortium (IPDGC), Nalls, M. A., et al. (2017) · Brain · doi:10.1093/brain/awx285 · Cited by 433
“Parkinson’s disease heritability remains incompletely explained by the genes and variants identified to date (Hamza and Paymi, 2010; Do et al., 2011; Keller et al., 2012; Verstraeten et al., 2015).”
BackgroundSelf-citationThe two-century journey of Parkinson disease research
Przedborski, S. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.25 · Cited by 345
Genome-wide pleiotropy between Parkinson disease and autoimmune diseases
Witoelar, A., Jansen, I. E., Wang, Y., Desikan, R. S., Gibbs, J. R., Blauwendraat, C., Thompson, W. K., Hernandez, D. G., Djurovic, S., Schork, A. J., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.0469 · Cited by 352
Self-citationBlauwendraat, C., Heilbron, K., Vallerga, C. L., Bandres‐Ciga, S., von Coelln, R., Pihlstrøm, L., Simón‐Sánchez, J., Schulte, C., Sharma, M., Krohn, L., et al. (2019) · Movement Disorders · doi:10.1002/mds.27659 · Cited by 338
“27.(5,47) Our heritability estimate was lower than an FIG.”
Self-citationDavis, L. K., Yu, D., Keenan, C. L., Gamazon, E. R., Konkashbaev, A. I., Derks, E. M., Neale, B. M., Yang, J., Lee, S. H., Evans, P., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003864 · Cited by 332
The Genetics of Parkinson’s Disease and Implications for Clinical Practice
Day, J. O., & Mullin, S. (2021) · Genes · doi:10.3390/genes12071006 · Cited by 234
“Genetic variation is estimated to contribute approximately 25% to the overall risk of developing PD [9,17,18].”
BackgroundWilson, G. R., Sim, J. C. H., McLean, C., Giannandrea, M., Galea, C. A., Riseley, J. R., Stephenson, S. E. M., Fitzpatrick, E., Haas, S. A., Pope, K., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.10.015 · Cited by 274
Guerreiro, R., Ross, O. A., Kun-Rodrigues, C., Hernandez, D. G., Orme, T., Eicher, J. D., Shepherd, C. E., Parkkinen, L., Darwent, L., Heckman, M. G., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30400-3 · Cited by 270
Self-citationGenetic risk factors in Parkinson’s disease
Billingsley, K. J., Bandres-Ciga, S., Saez-Atienzar, S., & Singleton, A. B. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2817-y · Cited by 249
Self-citationGenetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease
Gan-Or, Z., Dion, P. A., & Rouleau, G. A. (2015) · Autophagy · doi:10.1080/15548627.2015.1067364 · Cited by 260
Progress in unraveling the genetic etiology of Parkinson disease in a genomic era
Verstraeten, A., Theuns, J., & Van Broeckhoven, C. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.01.004 · Cited by 226
Genetics of Parkinson's disease – state of the art, 2013
Bonifati, V. (2014) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(13)70009-9 · Cited by 210
A Genome-Wide Association Study of Myasthenia Gravis
Renton, A. E., Pliner, H. A., Provenzano, C., Evoli, A., Ricciardi, R., Nalls, M. A., Marangi, G., Abramzon, Y., Arepalli, S., Chong, S., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.4103 · Cited by 206
Self-citationGenetic predispositions of Parkinson’s disease revealed in patient-derived brain cells
Tran, J., Anastacio, H., & Bardy, C. (2020) · npj Parkinson's Disease · doi:10.1038/s41531-020-0110-8 · Cited by 176
The prediagnostic phase of Parkinson's disease
Noyce, A. J., Lees, A. J., & Schrag, A.-E. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311890 · Cited by 173
“16 Over time, with increasing numbers of studied cases and controls, along with deep resequencing and precision phenotyping, a greater proportion of the heritability of PD will be uncovered.”
The concept of alpha-synuclein as a prion-like protein: ten years after
Steiner, J. A., Quansah, E., & Brundin, P. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2814-1 · Cited by 183
Iwaki, H., Blauwendraat, C., Leonard, H. L., Kim, J. J., Liu, G., Maple‐Grødem, J., Corvol, J., Pihlstrøm, L., van Nimwegen, M., Hutten, S. J., et al. (2019) · Movement Disorders · doi:10.1002/mds.27845 · Cited by 170
“Recent genomewide studies have identified 90 common variants associated with the risk of PD, with an overall heritability estimated to be between 22% to 27%.(2,3) Although previous studies have indicated the importance of genetic contributions to disease risk, the contribution of genetic factors to PD progression and…”
BackgroundSelf-citationHallacli, E., Kayatekin, C., Nazeen, S., Wang, X. H., Sheinkopf, Z., Sathyakumar, S., Sarkar, S., Jiang, X., Dong, X., Di Maio, R., et al. (2022) · Cell · doi:10.1016/j.cell.2022.05.008 · Cited by 169
An updated review of Parkinson's disease genetics and clinicopathological correlations
Ferreira, M., & Massano, J. (2017) · Acta Neurologica Scandinavica · doi:10.1111/ane.12616 · Cited by 167
Estimating the heritability of colorectal cancer
Jiao, S., Peters, U., Berndt, S. I., Brenner, H., Butterbach, K., Caan, B. J., Carlson, C. S., Chan, A. T., Chang-Claude, J. C., Chanock, S. J., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu087 · Cited by 145
Karimi-Moghadam, A., Charsouei, S., Bell, B., & Jabalameli, M. R. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0587-4 · Cited by 136
“Because PD is considered as a complex disease and causative loci may have different types of inheritance, the model of its inheritance is unknown (Keller et al. 2012).”
BackgroundMitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
Billingsley, K. J., Barbosa, I. A., Bandrés‐Ciga, S., Quinn, J. P., Bubb, V. J., Deshpande, C., Botía, J. A., Reynolds, R. H., Zhang, D., Simpson, M. A., et al. (2019) · npj Parkinson s Disease · doi:10.1038/s41531-019-0080-x · Cited by 155
Self-citationPolygenic risk of Parkinson disease is correlated with disease age at onset
Escott‐Price, V., for the International Parkinson's Disease Genomics Consortium, Nalls, M. A., Morris, H. R., Lubbe, S., Brice, A., Gasser, T., Heutink, P., Wood, N. W., Hardy, J., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24335 · Cited by 135
“For all significant associations the B-coefficients were positive, indicating that the higher polygenic score in the UK discovery sample corresponds to the higher score in each of the 3 independent replication samples and provides evidence for a polygenic contribution to the development of PD.”
BackgroundInfluentialSelf-citationHolmans, P., Moskvina, V., Jones, L., Sharma, M., Vedernikov, A., Büchel, F., Sadd, M., Brás, J., Bettella, F., Nicolaou, N., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds492 · Cited by 151
Self-citationFogh, I., Ratti, A., Gellera, C., Lin, K., Tiloca, C., Moskvina, V., Corrado, L., Soraru, G., Cereda, C., Corti, S., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt587 · Cited by 135
Self-citationConcordance for Parkinson's disease in twins: A 20‐year update
Goldman, S. M., Marek, K., Ottman, R., Meng, C., Comyns, K., Chan, P., Ma, J., Marras, C., Langston, J. W., Ross, G. W., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25441 · Cited by 111
Genetics of Parkinson's disease
Cherian, A., & Divya, K. P. (2020) · Acta Neurologica Belgica · doi:10.1007/s13760-020-01473-5 · Cited by 131
Epigenetic regulation in Parkinson’s disease
Labbé, C., Lorenzo-Betancor, O., & Ross, O. A. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1590-9 · Cited by 114
International Parkinson’s Disease Genetics Consortium (IPGDC), Jansen, I. E., Ye, H., Heetveld, S., Lechler, M. C., Michels, H., Seinstra, R. I., Lubbe, S. J., Drouet, V., Lesage, S., et al. (2017) · Genome Biology · doi:10.1186/s13059-017-1147-9 · Cited by 117
Self-citationGenetic Insights into Sporadic Parkinson's Disease Pathogenesis
Chai, C., & Lim, K. (2014) · Current Genomics · doi:10.2174/1389202914666131210195808 · Cited by 134
Variants in GBA , SNCA , and MAPT influence Parkinson disease risk, age at onset, and progression
Davis, A. A., Andruska, K. M., Benítez, B. A., Racette, B. A., Perlmutter, J. S., & Cruchaga, C. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.09.014 · Cited by 119
Reynolds, R. H., Botía, J., Nalls, M. A., International Parkinson’s Disease Genomics Consortium (IPDGC), Noyce, A. J., Nicolas, A., Cookson, M. R., Bandres-Ciga, S., Gibbs, J. R., Hernandez, D. G., et al. (2019) · npj Parkinson's Disease · doi:10.1038/s41531-019-0076-6 · Cited by 100
Self-citationCharacterizing the Genetic Architecture of Parkinson's Disease in Latinos
Loesch, D. P., Horimoto, A. R. V. R., Heilbron, K., Sarihan, E. I., Inca‐Martinez, M., Mason, E., Cornejo‐Olivas, M., Torres, L., Mazzetti, P., Cosentino, C., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26153 · Cited by 107
“Keller et al used GCTA to estimate the heritability of PD in European-ancestry cohorts; the 95% confidence interval of their overall estimate overlapped with the heritability estimated in LARGE-PD, while several cohorts had point estimates that were even higher than that estimated in LARGEPD.(45) This suggests that th…”
MethodResultGuerreiro, R., Escott-Price, V., Darwent, L., Parkkinen, L., Ansorge, O., Hernandez, D. G., Nalls, M. A., Clark, L., Honig, L., Marder, K., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.028 · Cited by 84
“…matrix between pairs of individuals, we performed a bivariate restricted maximum likelihood analysis on that matrix, as implemented in the software genome-wide complex trait analysis (Lee et al., 2012; Yang et al., 2010) using the fi rst 2 principal components from multidimensional scaling.”
MethodSelf-citationThe Evolution of Genetics: Alzheimer’s and Parkinson’s Diseases
Singleton, A., & Hardy, J. (2016) · Neuron · doi:10.1016/j.neuron.2016.05.040 · Cited by 91
Self-citationCoding mutations in NUS1 contribute to Parkinson’s disease
Guo, J., Zhang, L., Li, K., Mei, J., Xue, J., Chen, J., Tang, X., Shen, L. H., Jiang, H. F., Chen, C., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809969115 · Cited by 98
Dai, J., Shen, W., Wen, W., Chang, J., Wang, T., Chen, H., Jin, G., Ma, H., Wu, C. H., Li, L., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30447 · Cited by 92
Ibáñez, L., Dube, U., Saef, B. A., Budde, J., Black, K., Medvedeva, A., Del‐Aguila, J. L., Davis, A. A., Perlmutter, J. S., Harari, O., et al. (2017) · BMC Neurology · doi:10.1186/s12883-017-0978-z · Cited by 88
Novel Parkinson’s Disease Genetic Risk Factors Within and Across European PopulationsPreprint
(GP2), T. G. P. G. P., & Leonard, H. L. (2025) · medRxiv · doi:10.1101/2025.03.14.24319455 · Cited by 85
The genetics of Parkinson's disease
Mullin, S., & Schapira, A. (2015) · British Medical Bulletin · doi:10.1093/bmb/ldv022 · Cited by 78
Assessment of a Targeted Gene Panel for Identification of Genes Associated With Movement Disorders
Montaut, S., Tranchant, C., Drouot, N., Rudolf, G., Guissart, C., Tarabeux, J., Stemmelen, T., Velt, A., Fourrage, C., Nitschké, P., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.1478 · Cited by 88
Recent advances in Parkinson’s disease genetics
Lubbe, S. J., & Morris, H. R. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7003-2 · Cited by 85
“The current loci associated with PD account for only a very small amount (1–2 %) of the expected heritability of PD, with the number of confirmed loci likely to increase with the use of larger cohorts and/or next generation sequencing technologies [77].”
BackgroundSelf-citationAssessing the contribution of the chemical exposome to neurodegenerative disease
Lefèvre‐Arbogast, S., Chaker, J., Mercier, F., Barouki, R., Coumoul, X., Miller, G. W., David, A., & Samieri, C. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01627-1 · Cited by 81
Mokretar, K., Pease, D., Taanman, J., Soenmez, A., Ejaz, A., Lashley, T., Ling, H., Gentleman, S., Houlden, H., Holton, J. L., et al. (2018) · Brain · doi:10.1093/brain/awy157 · Cited by 81
Missing heritability of common diseases and treatments outside the protein-coding exome
Sadee, W., Hartmann, K., Seweryn, M., Pietrzak, M., Handelman, S. K., & Rempala, G. A. (2014) · Human Genetics · doi:10.1007/s00439-014-1476-7 · Cited by 71
Genetic comorbidities in Parkinson's disease
Nalls, M. A., Saad, M., Noyce, A. J., Keller, M. F., Schrag, A. E., Bestwick, J., Traynor, B. J., Gibbs, J. R., Hernandez, D. G., Cookson, M., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt465 · Cited by 80
Self-citationBenitez, B. A., Davis, A. A., Jin, S. C., Ibanez, L., Ortega-Cubero, S., Pastor, P., Choi, J., Cooper, B., Perlmutter, J. S., & Cruchaga, C. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0097-0 · Cited by 75
“The currently identified genetic factors explain only 6–7 % of the phenotypic variability associated with PD [12], and the most prevalent GWA signals account for only 3–5 % of PD genetic variance in individuals of European ancestry [12].”
BackgroundBraudt, D. B. (2018) · Sociology Compass · doi:10.1111/soc4.12626 · Cited by 76
Drosophila Models of Sporadic Parkinson’s Disease
Nagoshi, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113343 · Cited by 75
“Like many other genetic risk factors identified in GWAS, the association of GAK with PD risk may depend on the ethnic background and is replicated mainly in Caucasian populations [81,194].”
BackgroundInfluentialCRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease
Rahman, M. U., Bilal, M., Shah, J. A., Kaushik, A. K., Teissèdre, P., & Kujawska, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061252 · Cited by 70
Leonard, H. L., Blauwendraat, C., Krohn, L., Faghri, F., Iwaki, H., Ferguson, G. D., Day-Williams, A., Stone, D. J., Singleton, A., Nalls, M. A., et al. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106283 · Cited by 68
Self-citationPIAS2-mediated blockade of IFN-β signaling: a basis for sporadic Parkinson disease dementia
Magalhaes, J., Tresse, E., Ejlerskov, P., Hu, E., Liu, Y., Marin, A., Montalant, A., Satriano, L., Rundsten, C. F., Carlsen, E. M. M., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01207-w · Cited by 65
Self-citationGenotype-Environment Correlation in the Era of DNA
Plomin, R. J. (2014) · Behavior Genetics · doi:10.1007/s10519-014-9673-7 · Cited by 71
Malassezia and Parkinson's Disease
Laurence, M., Benito‐León, J., & Calon, F. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00758 · Cited by 70
Parkinson's disease – genetic cause
Cherian, A., Divya, K. P., & Vijayaraghavan, A. (2023) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001167 · Cited by 70
“GWAS require large numbers of cases andwell matched population controls [11].”
Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease
Imbriani, P., Martella, G., Bonsi, P., & Pisani, A. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105851 · Cited by 67
“In the last two decades, the identification of several PD-risk associated genes (Karimi-Moghadam et al., 2018; Keller et al., 2012; Klein and Westenberger, 2012; Spatola and Wider, 2014; Yao et al., 2021) has provided incredible advance to our understanding of the molecular pathways involved in disease pathogenesis.”
Lubbe, S. J., Escott-Price, V., Gibbs, J. R., Nalls, M. A., Bras, J., Price, T. R., Nicolas, A., Jansen, I. E., Mok, K. Y., Pittman, A. M., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw348 · Cited by 61
“However, 5–10% of patients with PD, depending on the population, have a recognized pathogenic Mendelian cause, and common variants only contribute 5% of the genetic heritability (3), indicating that the majority of genetic inheritance is unexplained.”
Self-citationParkinson's Disease: Risk Factor Modification and Prevention
Rajan, S. M., & Kaas, B. M. (2022) · Seminars in Neurology · doi:10.1055/s-0042-1758780 · Cited by 62
Morphometricity as a measure of the neuroanatomical signature of a trait
Sabuncu, M. R., Ge, T., Holmes, A. J., Smoller, J. W., Buckner, R. L., Fischl, B. R., Initiative, T. A. D. N., Weiner, M. W., Aisen, P., Weiner, M. W., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604378113 · Cited by 65
Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes
Vacic, V., Ozelius, L. J., Clark, L. N., Bar‐Shira, A., Gana‐Weisz, M., Gurevich, T., Gusev, A., Kedmi, M., Kenny, E. E., Liu, X., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu158 · Cited by 63
Genome-wide estimate of the heritability of Multiple System Atrophy
Federoff, M., Price, T. R., Sailer, A., Scholz, S. W., Hernandez, D. G., Nicolas, A., Singleton, A., Nalls, M. A., & Houlden, H. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.11.005 · Cited by 52
Self-citationSchmeißer, K., & Parker, J. A. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007561 · Cited by 51
Parkinson’s Disease Genetic Loci in Rapid Eye Movement Sleep Behavior Disorder
Gan‐Or, Z., Girard, S., Noreau, A., Leblond, C. S., Gagnon, J., Arnulf, I., Mirarchi, C., Dauvilliers, Y. A., Désautels, A., Mitterling, T., et al. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0569-7 · Cited by 50
Identification of genetic modifiers of age-at-onset for familial Parkinson’s disease
Hill‐Burns, E. M., Ross, O. A., Wissemann, W. T., Soto‐Ortolaza, A. I., Zareparsi, S., Siuda, J. S., Lynch, T., Wszołek, Z. K., Silburn, P. A., Mellick, G. D., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw206 · Cited by 52
Siitonen, A., Nalls, M. A., Hernandez, D. G., Gibbs, J. R., Ding, J., Ylikotila, P., Edsall, C. W., Singleton, A., & Majamaa, K. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.01.019 · Cited by 50
Self-citationGenome-wide assessment of Parkinson's disease in a Southern Spanish population
Bandrés‐Ciga, S., Price, T. R., Barrero, F. J., Sevilla, F. E., Pelegrina, J., Arepalli, S., Hernandez, D. G., Gutiérrez, B., Cervilla, J. A., Rivera, M., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.06.001 · Cited by 45
Self-citationEpigenetic Modulation in Parkinson’s Disease and Potential Treatment Therapies
Rathore, A. S., Birla, H., Singh, S. S., Zahra, W., Dilnashin, H., Singh, R., Keshri, P. K., & Singh, S. P. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03334-w · Cited by 49
Multi-omic insights into Parkinson's Disease: From genetic associations to functional mechanisms
Schilder, B. M., Navarro, E., & Raj, T. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105580 · Cited by 48
Weil, R. S., Lashley, T., Brás, J., Schrag, A. E., & Schott, J. M. (2017) · F1000Research · doi:10.12688/f1000research.11725.1 · Cited by 49
Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation
Belloli, S., Morari, M., Murtaj, V., Valtorta, S., Moresco, R. M., & Gilardi, M. C. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00152 · Cited by 43
Genetics of movement disorders in the next‐generation sequencing era
Olgiati, S., Quadri, M., & Bonifati, V. (2016) · Movement Disorders · doi:10.1002/mds.26521 · Cited by 45
Genome-wide contribution of common short-tandem repeats to Parkinson’s disease genetic risk
Bustos, B. I., Billingsley, K. J., Blauwendraat, C., Gibbs, J. R., Gan‐Or, Z., Krainc, D., Singleton, A., & Lubbe, S. J. (2022) · Brain · doi:10.1093/brain/awac301 · Cited by 44
Self-citationGo, R. C. P., Corley, M. J., Ross, G. W., Petrovitch, H., Masaki, K., Maunakea, A. K., He, Q., & Tiirikainen, M. (2020) · BMC Neuroscience · doi:10.1186/s12868-020-00582-4 · Cited by 46
Kuhlmann, N., & Milnerwood, A. J. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00153 · Cited by 38
Liscovitch, N., & French, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115029 · Cited by 43
“variance explained by all common variants [2].”
Parkinson's disease risk genes act in glia to control neuronal α-synuclein toxicity
Olsen, A. L., & Feany, M. Β. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105482 · Cited by 37
Usefulness of Genetic Testing in PD and PD Trials: A Balanced Review
Gasser, T. (2015) · Journal of Parkinson’s Disease · doi:10.3233/jpd-140507 · Cited by 35
“Even if all known risk factors are considered together, they are only associated with an odds ratio of 3 to 4 [7] and thus explain only a part of the expected heritability of PD [27].”
Self-citationDocherty, A. R., Moscati, A., Peterson, R. E., Edwards, A. C., Adkins, D. E., Bacanu, S., Bigdeli, T. B., Webb, B. T., Flint, J., & Kendler, K. S. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.177 · Cited by 35
Zou, M., Li, R., Wang, J., Wang, K., Wang, Y., Yang, L., Ji, F.-X., Sun, S.-N., Huang, S., Fan, H.-H., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.005 · Cited by 33
Association Studies of Sporadic Parkinson’s Disease in the Genomic Era
Labbé, C., & Ross, O. A. (2014) · Current Genomics · doi:10.2174/1389202914666131210212745 · Cited by 33
“calculated that 27% of the phenotypic variance is explained for PD in general, 15% for early-onset PD and 24% for late-onset PD [44].”
BackgroundGenetic variation associated with the occurrence and progression of neurological disorders
Little, J., Barakat, C., Martino, R., Pringsheim, T. M., Tremlett, H. L., McKay, K. A., Lieshout, P. H. H. M. V., Walsh, S. J., Gomes, J., & Krewski, D. R. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.09.018 · Cited by 30
Ten Years of the International Parkinson Disease Genomics Consortium: Progress and Next Steps
The International Parkinson Disease Genomics Consortium (IPDGC) (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191854 · Cited by 32
Genetic markers of Restless Legs Syndrome in Parkinson disease
Gan‐Or, Z., Alcalay, R. N., Bar‐Shira, A., Leblond, C. S., Postuma, R. B., Ben‐Shachar, S., Waters, C., Johnson, A., Levy, O., Mirelman, A., et al. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.03.010 · Cited by 28
“[5, 6] In PD, estimates of the genetic susceptibility component range from 27% to 60%, yet known genetic markers can only explain up to 7% of PD cases, [7-9] suggesting that there are still other genetic variants that are either rare or with a small effect size, that can influence PD risk.”
Open questions on the nature of Parkinson’s disease: from triggers to spreading pathology
Mou, L., Ding, W., & Fernández-Fúnez, P. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106210 · Cited by 29
Genomic aspects of sporadic neurodegenerative diseases
Mitsui, J., & Tsuji, S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.098 · Cited by 27
What have we learned from genome-wide association studies (GWAS) in Parkinson's disease?
Fernández‐Santiago, R., & Sharma, M. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101648 · Cited by 28
Self-citationKõks, S., Pfaff, A. L., Singleton, L. M., Bubb, V. J., & Quinn, J. P. (2022) · Experimental Biology and Medicine · doi:10.1177/15353702221117147 · Cited by 26
Genomic convergence of locus-based GWAS meta-analysis identifies AXIN1 as a novel Parkinson’s gene
Saeed, M. (2018) · Immunogenetics · doi:10.1007/s00251-018-1068-0 · Cited by 28
Multiple system atrophy: the application of genetics in understanding etiology
Federoff, M., Schottlaender, L., Houlden, H., & Singleton, A. (2015) · Clinical Autonomic Research · doi:10.1007/s10286-014-0267-5 · Cited by 26
“This method has been successfully applied in diseases such as PD, where the heritable component attributable to common variants was estimated to be 30 % [141].”
MethodSelf-citationS100B polymorphisms are associated with age of onset of Parkinson’s disease
Fardell, C., Zettergren, A., Ran, C., Belin, A. C., Ekman, A., Sydow, O., Bäckman, L., Holmberg, B., Dizdar, N., Söderkvist, P., et al. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0547-3 · Cited by 25
“However, according to genome-wide complex trait analysis there are substantially more risk loci to be identified [12].”
BackgroundSelective dopaminergic vulnerability in Parkinson’s disease: new insights into the role of DAT
Harraz, M. M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1219441 · Cited by 26
“Yet, recent studies implicate a significant role of heredity in PD that was not previously appreciated, suggesting that 27 to 60% is due to genetic factors (Hamza and Payami, 2010; Do et al., 2011; Keller et al., 2012).”
BackgroundDeep phenotyping for precision medicine in Parkinson's disease
Schalkamp, A., Rahman, N., Monzón‐Sandoval, J., & Sandor, C. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049376 · Cited by 27
The pallidopyramidal syndromes: nosology, aetiology and pathogenesis
Kara, E., Hardy, J., & Houlden, H. (2013) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283632e83 · Cited by 25
Self-citationShulskaya, M. V., Alieva, A. K., Vlasov, I. N., Zyrin, V., Fedotova, E. Y., Abramycheva, N. Y., Usenko, T. S., Yakimovsky, A. F., Emelyanov, A., Пчелина, С. Н., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00136 · Cited by 22
“Analysis of all available studies of the familial form of PD indicates that the fraction of monogenic forms does not account for more than 10% of all cases, whereas the expected number of cases attributable from a genetic viewpoint is 27%–40% (Hamza and Payami, 2010; Keller et al., 2012).”
BackgroundDeng, X., Ning, Y., Saffari, S. E., Xiao, B., Niu, C., Ng, S. Y., Chia, N. S. Y., Choi, X., Heng, D. L., Tan, Y. J., et al. (2023) · European Journal of Neurology · doi:10.1111/ene.15785 · Cited by 21
“Using genome-wide complex trait analysis, 27% of the genetic variants associated with PD, which is dramatically higher than 3%– 5% of the genetic variants identified by top genome-wide association studies alone [ 18 ].”
Background
Metadata
- Authors
- Keller, M. F., Saad, M., Bras, J., Bettella, F., Nicolaou, N., Simon-Sanchez, J., Mittag, F., Buchel, F., Sharma, M., Gibbs, J. R., Schulte, C., Moskvina, V., Durr, A., Holmans, P., Kilarski, L. L., Guerreiro, R., Hernandez, D. G., Brice, A., Ylikotila, P., Stefansson, H., Majamaa, K., Morris, H. R., Williams, N., Gasser, T., Heutink, P., Wood, N. W., Hardy, J., Martinez, M., Singleton, A. B., Nalls, M. A., & for the International Parkinson's Disease Genomics Consortium (IPDGC) and The Wellcome Trust Case Control Consortium 2 (WTCCC2)
- Affiliations
- National Institutes of Health (US)
- Université Toulouse III - Paul Sabatier (FR)
- deCODE Genetics (Iceland) (IS)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Inserm (FR)
- German Center for Neurodegenerative Diseases (DE)
- Cardiff University (GB)
- UCL Queen Square Institute of Neurology (GB)
- Centre National de la Recherche Scientifique (FR)
- University of Turku (FI)
- University of Oulu (FI)
- Corresponding author
- Nalls, M. A.
- ORCID
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-08-13
- Volume
- 21
- Issue
- 22
- Pages
- 4996-5009
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC3576713
- OpenAlex
- W2132869184
- Cited by
- 190
- References
- 51
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 8 · 2023: 5 · 2022: 18 · 2021: 11 · 2020: 13 · 2019: 18 · 2018: 22 · 2017: 17 · 2016: 21 · 2015: 18 · 2014: 18 · 2013: 9 · 2012: 2
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Human Molecular Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Research Portal (Queen's University Belfast) (publishedVersion, other-oa)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion)
- CLOK (University of Central Lancashire) (submittedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Site cant be reached (submittedVersion)
- DZNE Pub (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Wellcome Trust (083948/Z/07/Z, 090532, 089698, WT089698/Z/09/Z)
- National Institute for Health and Care Research (NF-SI-0507-10376)
- Parkinson's UK (G0909, J-0901, G-1107, J‐0804)
- National Institutes of Health (1z01es101986-03, UL1TR000448, Z01-ES101986, Z01-AG000949)
- Medical Research Council (MC_G1000735, MC_PC_09003, MC_G0901330)
- National Institute on Aging (Z01AG000949)
- National Institute of Neurological Disorders and Stroke (P30NS057105, NS057105, R01NS041509, R01NS075321)
- National Institute of Environmental Health Sciences (Z01-ES 101986)
- National Center for Research Resources (RR-024992, UL1RR024992)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and phenotypic traits in livestock
- Keywords
- Parkinson's disease, missing heritability, GCTA, heritability, early-onset Parkinson's disease, late-onset Parkinson's disease, genetic susceptibility loci
- MeSH terms
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Parkinson Disease, Genetic Variation, Quantitative Trait, Heritable, Genetic Predisposition to Disease, Multifactorial Inheritance, White People, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.